Neuroimaging techniques have been essential in clinical #neuroscience for decades but have yet to make a significant impact on psychiatric drug development and clinical care. By integrating neuroimaging into precision psychiatry, we can measure drug effects on the brain early to refine dosing and indications and use it in later trials to identify likely responders. This approach has the potential to enhance drug development success, diversify mechanisms, and improve clinical outcomes. In a recent Nature publication, researchers take an industry lens to examine the opportunities and challenges in using #neuroimaging to mitigate risks in drug development and improve clinical efficacy in psychiatric practice, ultimately paving the way for more precise and effective treatments. See here: https://lnkd.in/dUQYTwni
